ImClone and Bristol-Myers's Erbitux and Amgen's Vectibix Label Change Approved for KRAS Gene - Health Blog - WSJ
Links shared publicly online about this topic.
- 1,884total visits
ImClone and Bristol-Myers's Erbitux and Amgen's Vectibix Label Change Approved for KRAS Gene - Health Blog - WSJ
Patients with mutations to the KRAS gene won't benefit from these medicines.
View full resource at blogs.wsj.com
Tags: Colorectal Cancer Medication, Genes, Erbitux, Vectibix, Bristol-Myers Squibb, Amgen
Most Recently Shared on July 20, 2009 at 2:47 pm By:
Erbitux, Vectibix Label Change Approved for KRAS Gene http://bit.ly/bXIJ4
Advertisement
